Bioxcel TherapeuticsBTAIQ
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 49 institutions reported holding Bioxcel Therapeutics Inc. (BTAIQ) in their 13F filings, down 1 from Q3 2024. 7 opened new positions and 10 sold out. The largest holders were Armistice Capital, LLC ($1.6M), UBS Group AG ($478K) and Vanguard Group Inc. ($444K). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Bioxcel Therapeutics Inc.
- CUSIP
- 09075P105
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $1.6M |
| Exits | 10 | $43K |
All 13F filers, Q3 2024 → Q4 2024: 5,790,339 shares bought and 330,726 shares sold, net +5,459,613 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 49 holders
| Armistice Capital, LLC | 0.04% | New | 4,315,000 | $1.6M |
| UBS Group AG | 0.00% | Add +9553.0% | 1,276,893 | $478K |
| Vanguard Group Inc. | 0.00% | Reduce -1.2% | 1,187,466 | $444K |
| BlackRock, Inc. | 0.00% | Add +5.0% | 380,608 | $142K |
| Geode Capital Management, LLC | 0.00% | Add +4.7% | 311,965 | $117K |
| Wells Fargo & Company | 0.00% | Add +7.5% | 199,010 | $74K |
| Millennium Management | 0.00% | Reduce -18.5% | 104,972 | $39K |
| Renaissance Technologies | 0.00% | Reduce -40.0% | 77,900 | $29K |
| State Street Corp. | 0.00% | No change | 77,149 | $29K |
| Northern Trust Corp. | 0.00% | Add +81.4% | 73,910 | $28K |
| Squarepoint Ops LLC | 0.00% | Add +203.9% | 72,046 | $27K |
| Bank of America Corp. | 0.00% | Reduce -36.7% | 52,952 | $20K |
| Alpha Zero LLC | 0.01% | — | 52,350 | $20K |
| Diversify Wealth Management, LLC | 0.00% | No change | 40,000 | $15K |
| Arete Wealth Advisors, LLC | 0.00% | No change | 40,500 | $15K |
| Hennion & Walsh Asset Management, Inc. | 0.00% | Reduce -1.8% | 39,368 | $15K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | No change | 38,050 | $14K |
| Susquehanna International Group, LLP | 0.00% | Add +0.9% | 34,531 | $13K |
| Morgan Stanley | 0.00% | Reduce -36.5% | 25,796 | $10K |
| HRT Financial LP | 0.00% | New | 25,505 | $9K |
| Jane Street Group, LLC | 0.00% | Reduce -52.7% | 23,343 | $9K |
| Group One Trading LLC | 0.00% | Reduce -39.9% | 18,116 | $7K |
| Two Sigma Securities, LLC | 0.00% | New | 17,316 | $6K |
| Virtu Financial LLC | 0.00% | New | 16,983 | $6K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.00% | Add +5.0% | 15,939 | $6K |
| Osaic Holdings, Inc. | 0.00% | Add +75.0% | 14,875 | $6K |
| LPL Financial LLC | 0.00% | Reduce -17.1% | 14,544 | $5K |
| SBI Securities Co., Ltd. | 0.00% | — | 12,701 | $5K |
| Engineers Gate Manager LP | 0.00% | New | 11,985 | $4K |
| DAVENPORT & Co LLC | 0.00% | Reduce -29.9% | 11,810 | $4K |
| Tocqueville Asset Management L.P. | 0.00% | Reduce -0.8% | 11,800 | $4K |
| SeaCrest Wealth Management, LLC | 0.00% | Reduce -9.7% | 11,150 | $4K |
| Federated Hermes, Inc. | 0.00% | No change | 4,819 | $2K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 4,262 | $2K |
| Washington Trust Advisors, Inc. | 0.00% | No change | 2,572 | $962 |
| BNP Paribas Financial Markets | 0.00% | Reduce -94.8% | 2,321 | $868 |
| Parkside Financial Bank & Trust | 0.00% | No change | 1,800 | $674 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0.00% | Reduce -72.6% | 1,653 | $618 |
| JPMorgan Chase & Co. | 0.00% | Add +77.3% | 1,328 | $496 |
| National Bank of Canada | 0.00% | Reduce -57.0% | 1,020 | $381 |
| NewEdge Advisors, LLC | 0.00% | No change | 500 | $187 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 340 | $127 |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -97.7% | 259 | $97 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 113 | $42 |
| Farther Finance Advisors, LLC | 0.00% | New | 95 | $36 |
| Barclays PLC | 0.00% | No change | 88 | $33 |
| Point72 (DIFC) Ltd | 0.00% | Add +12.9% | 35 | $13 |
| US Bancorp \de | 0.00% | Reduce -99.8% | 33 | $12 |
| Hantz Financial Services, Inc. | 0.00% | No change | 50 | $0 |
"% of holder's portfolio" is BTAIQ's weight in each manager's 13F, not the share of Bioxcel Therapeutics Inc. the manager owns.